NovAccess Global Inc.

Pharmaceutical Preparations·CHAGRIN FALLS, OH

CEO

Morris-Irvin Dwain

CFO

Laird Neil J

Summary Financials

Revenue

FY 2024

Adj. EBITDA

-$2.5M

FY 2024

Net Income

-$4.7M

FY 2024

EPS (Diluted)

-$0.23

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$21,415

FY 2024

Total Debt

$186,880

FY 2021

Net Debt

$165,465

FY 2021

Enterprise Value

—

Debt / EBITDA

-0.1x

FY 2024

EV / EBITDA

—

Employees

—

Revenue

FY 2024

Adj. EBITDA

-$2.5M

FY 2024

Net Income

-$4.7M

FY 2024

EPS (Diluted)

-$0.23

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$21,415

FY 2024

Total Debt

$186,880

FY 2021

Net Debt

$165,465

FY 2021

Enterprise Value

—

Debt / EBITDA

-0.1x

FY 2024

EV / EBITDA

—

Employees

—